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Abstract
Background: Angelman syndrome (AS) is a neurodevelopmental disorder. AS patients concomitant with sSMC are
rather rare events. It will provide more useful and proper information for genetic counseling to identify the sSMC origin.
Case presentation: A 27-year-old woman was referred for genetic counseling and prenatal diagnosis at 26 weeks of
gestation due to her elder daughter, diagnosed as Angelman syndrome (AS) with an interstitial deletion in one of the
chromosomes 15, carrying a small supernumerary marker chromosome (sSMC). The G-banding results of the woman
and her current fetus both were 47,XX,+mar. In this paper, fluorescence in situ hybridization (FISH) results showed that
there was no deletion of chromosome 15 in the woman and fetus. We demonstrated that the proband’s sSMC was
maternally inherited and was an inv dup(22)(q11.1) , and that the deletion in 15q11.2-q13.1 was de novo.
Conclusions: Taking into account above results and normal phenotypes of the proband’s mother, in this case we
suggest that the sSMC don’t increase the recurrence risk of AS. After prenatal diagnosis, the woman chose to continue
the pregnancy, and finally gave birth to a normal female infant.
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Background
Angelman syndrome (AS) is a neurodevelopmental dis-
order. Main clinical characteristics of AS include severe
developmental delay, speech impairment, movement or
balance disorder and apparent happy demeanor. Genetic
mechanisms of AS involved the commonest, (micro) dele-
tions in maternal chromosome 15q11-13, paternal unipa-
rental disomy 15 (UPD), imprinting defects and/or
mutation in the disease-causing gene UBE3A (ubiquitin
protein ligase E3A) [OMIM:105830] [1].
Small supernumerary marker chromosomes (sSMC) are
defined as structurally abnormal chromosomes that can-
not be identified or characterized unambiguously by
conventional banding cytogenetics alone. The size of
sSMC is generally equal to or smaller than a chromosome
20 of the same metaphase spread [2]. The incidence has
been estimated to be 0.075 % in unselected prenatal cases
and 0.044 % in newborn infants, but evelated to 0.288 %
in mentally retarded patients [3]. Furthermore, 70 % of
sSMC are derived from acrocentric chromosomes [2].
As far as we know, there were rare nine AS cases re-
ported in connection with sSMC. All AS cases with sSMC
reported were related to chromosome 15. It is generally
considered that the sSMC derived from chromosome 15
and contained the Prader–Willi/Angelman syndrome crit-
ical region (PWACR) would cause clinical phenotypes.
We reported a previous case of AS with sSMC derived
not from chromosome 15 [4]. At that time, we excluded
the possibility of paternally- inherited origin of sSMC, but
couldn’t deduce whether the origin of sSMC was de novo
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or maternally inherited. In this paper, the proband’s
mother gave her consent to genetic testing and counselled
for her fetus. In order to evaluate the recurrence risk of
AS correctly, we made clear that the proband’s sSMC was
maternally inherited and was an inv dup(22)(q11.1), and
that the deletion in 15q11.2-q13.1 was de novo. Prenatal
diagnosis and genetic counseling was performed in view
of the findings.
Case presentation
A 27-year-old woman was referred for genetic counseling
and prenatal diagnosis at 26 weeks of gestation because
her first daughter was diagnosed as Angelman syndrome
(AS) due to a 5.058 Mb deletion in chromosome band
15q11.2-q13.1 and with a small supernumerary marker
chromosome (sSMC). The proband was born by the
woman and her former husband. Neither with her former
husband nor with her current husband, they were in a
non-consanguineous marriage. There was no family his-
tory of miscarriage or congenital malformations from ei-
ther the two-term husbands or the woman. No abnormal
symptoms were observed, and physical examination
revealed that the couple was phenotypically normal.
The proband was diagnosed as AS at 3-year-old. G-
banding revealed a karyotype 47,XX,+mar in all of the
peripheral blood lymphocytes. Her paternal karyotype was
normal and the information of her mother was unknown
formerly. Silver staining for the nucleolus organizer re-
gions (NOR staining) revealed two satellites in both ends
of the sSMC. Fluorescence in situ hybridization (FISH)
using the 15 dual color DNA probes (Vysis, USA), which
hybridize to D15S10,UBE3A and centromere of chromo-
some 15 confirmed the deletion of chromosome 15q11-13
and the sSMC was unrelated with chromosome 15.
Material and methods
Cytogenetic analysis
Peripheral blood from the woman and cord blood from
the fetus were drawn for cytogenetic analysis including
G-banding and fluorescence in situ hybridization (FISH).
FISH using the 15 dual color DNA probes (Vysis, USA)
was performed according to standard procure. Centro-
meric FISH probes for chromosome 14 and 22, followed
by sub-centromeric FISH probes for chromosome 14 or
22 were adopted to identify the the origin of sSMC in
the proband. Centromere FISH and sub-centromere
FISH were kindly performed by the laboratory of Profes-
sor Thomas Liehr (Jena University Hospital, Friedrich
Schiller University, Institute of Human Genetics).
Results
G-banding showed both of karyotypes in woman and
her fetus were 47,XX,+mar in 100 % of the analyzed
cells.. This revealed the small supernumerary marker
chromosome (sSMC) in the proband was maternally
inherited. Fluorescence in situ hybridization confirmed
that there was no deletion of chromosome 15q11-13 in
the woman and her fetus, therefore Angelman syndrome
Fig. 1 Results of karyotypes and FISH using the 15 dual color DNA probes. a–c: The results of karyotypes from the mother (a), the fetus (b) and
the proband (c) showed the sSMC in the proband and the fetus were maternally inherited. The black arrow indicates the sSMC. d–f: The results of
FISH using the 15 dual color DNA probes showed that there was no deletion in chromosome 15q11-13 observed both in the mother (d) and in
the fetus (e) and that there was no additional centromeric signal of chromosome 15 in the three cases. The white arrow(↓) shows the loss of
chromosome 15q11-13 and the white arrow to left (←) indicates normal chromosome 15 in the proband (f). The orange signals indicate
chromosome 15q11-13 and 15q22-24(used as control probe), the green signal indicates the centromere of chromosome 15. a, d: the mother
of proband; b, e: the fetus; c, f: the proband
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was not considered. FISH analysis with centromeric
probe of chromosome 15 also excluded the possibility of
the origin from the chromosome 15 (Fig. 1).
Centromeric FISH and sub-centromeric FISH on the
proband’s metaphases spreads demonstrated that the
sSMC originated from chromosome 22 and was a variant
of inv dup(22)(q11.1) (Fig. 2), thus the final karyotype of
the proband was written as 47,XX,del(15)(q11q13),+inv
dup(22)(q11.1).
Discussion
Angelman syndrome (AS) has a prevalence of 1/10,000 ~
1/20,000 individuals [1], it could be clinically diagnosed by
a serial of characteristic features including developmental
delay, intellectual disability, speech impairment, seizures,
movement or balance disorder, apparent happy demeanor,
and so on. Genetic analysis, such as karyotype, fluores-
cence in situ hybridization (FISH), methylation analysis of
the chromosome 15q11-13 region and chromosomal mi-
croarrays analysis might be helpful for the diagnosis of AS
and provide information as much as possible for genetic
counseling. In our previous report, Affymetrix cytogenet-
ics whole genome 2.7 M arrays were applied to demon-
strate a 5.058 Mb deletion in chromosome band 15q11.2-
q13.1 between positions chr15: 21,170,573-26,229,285 bp,
in which 10 genes (SNORD116-14, SNORD115-30,
UBE3A, SNORD109B, SNORD115-23, SNORD116-9,
SNORD116-16, SNORD115-10, GABRG3, SNORD116-2)
were contained. The microarrays analysis further charac-
terized the region confirmed by FISH.
What’s special about the AS proband we reported was
accompanied by a small supernumerary marker chromo-
some (sSMC). AS patients concomitant with sSMC are ra-
ther rare events. Just nine AS cases with the sSMC were
reported by now. As summarized in sSMC-homepage
(http://ssmc-tl.com/sSMC.html), the corresponding sSMC
were derived from chromosome 15 in all nine cases. In
five of them, the AS was due to a paternal UPD 15, in
three due to a deletion in the AS-critical region [5–8] and
in the remainder case the molecular result for AS was not
elucidated. Chromosome 15 is the most common origin
of sSMC in human [2, 3]. Summarizing data indicated that
the majority of sSMCs (65 %) originated from chromo-
some 15, while sSMCs derived from other acrocentric
chromosomes 13, 14, 21, and 22 constitute only 7 % [9].
When AS accompanied by sSMC, particularly contained
the Prader–Willi/Angelman syndrome critical region in
chromosome 15, the correlation between the genotype
and the clinical phenotype became more complex [10].
The abnormal phenotype was associated with the origin
and genetic nature of sSMC. It is important to identify the
chromosome origin if the sSMC is visible in the karyotype
of AS.
In our case, karyotypes showed the sSMC was mater-
nally inherited. Furthermore, FISH with centromeric
probe of chromosome 15 revealed that the sSMC was un-
related to chromosome 15. Finally, Centromeric FISH and
sub-centromeric FISH were carried out to confirm that
the sSMC derived from chromosome 22 and was an inv
dup(22)(q11.1) (Fig. 2). Additionally, data from Affymetrix
cytogenetics whole genome 2.7 M arrays did not indicate
the origin information. We speculated that the genetic
material nature of the sSMC was heterochromatin and
there was no annotated gene present corresponding to the
arrays. Thus, the proband we reported previously, to our
knowledge, is the first AS case with the maternally inher-
ited sSMC derived from chromosome 22.
The risk to the sibs of an individual with AS who was
identified a de novo large deletion in the chromosome
15q11-13 is reported < 1 % [11]. However, it is estimated
that there were about 2.7x106 living sSMC carriers in
the world, almost 70 % of those are clinically normal
[12]. Furthermore, in 70 % of the carriers the sSMC is
de novo, in 20 % inherited from the mother, and in 10 %
inherited from the father. Familial sSMCs in general
have little or no effect on the phenotype if the parent’s
development is normal [13].
Taking into account the normal phenotype of the pro-
band’s mother, we thought that AS in the proband could
be explained by the microdeletion on one of the
chromosome 15q11-13, and not by the presence of the
sSMC.
Fig. 2 The origin of marker chromosome characterized by centromeric FISH and subcentromeric FISH. a: The sSMC wasn’t derived from chromosome
14. The centromeric probe specific for chromosome 14 / 22(D14/22Z1 blue) and a probe specific for all acrocentric p-arms (acro-p red) were present on
the marker chromosome. But the centromere-near probe in 14q11.2(RP11-332 N6 green) was not detected on the marker chromosome. b: The sSMC
originated from chromosome 22 and was an inv dup(22)(q11.1). The centromeric probe specific for chromosome 22(D22Z4 red) and a probe specific
for all acrocentric p-arms (acro-p blue) were present on the marker chromosome. A centromere-near probe in 22q11.21(RP11-172D7 green) was not
detected.14:chromosome 14; 22: chromosome 22; mar: sSMC
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After prenatal diagnosis and genetic counseling, the
woman chose to continue the pregnancy, and finally
gave birth to a normal female infant.
Conclusion
In summary, the recurrence risk of AS depends on the
genetic mechanism of AS in the proband. When AS
accompanied by sSMC, it will provide more useful and
proper information for genetic counseling to identify the
sSMC origin.
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